Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Stuart

Showing results (271-280 of 313) with videos related to

Pageof 32
Sort By:
Nature Communications|June 7, 2023
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapyManon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Proteins|November 25, 2004
Design of a data model for developing laboratory information management and analysis systems for protein productionAnne Pajon, John Ionides, Jon Diprose, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Site-specific steric control of SARS-CoV-2 spike glycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Cell Host & Microbe|June 26, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Cell Host & Microbe|September 10, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Biochemistry|July 2, 2021
Site-Specific Steric Control of SARS-CoV-2 Spike GlycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Antiviral Research|December 1, 2009
Structure and functionality in flavivirus NS-proteins: perspectives for drug designMichela Bollati, Karin Alvarez, René Assenberg, et al.
Nature Methods|June 20, 2017
High-speed fixed-target serial virus crystallographyPhilip Roedig, Helen M Ginn, Tim Pakendorf, et al.
Pageof 32

Showing results (271-280 of 313) with videos related to

Sort By:
Pageof 32
Nature Communications|June 7, 2023
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapyManon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Proteins|November 25, 2004
Design of a data model for developing laboratory information management and analysis systems for protein productionAnne Pajon, John Ionides, Jon Diprose, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Site-specific steric control of SARS-CoV-2 spike glycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Cell Host & Microbe|June 26, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Cell Host & Microbe|September 10, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Biochemistry|July 2, 2021
Site-Specific Steric Control of SARS-CoV-2 Spike GlycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Antiviral Research|December 1, 2009
Structure and functionality in flavivirus NS-proteins: perspectives for drug designMichela Bollati, Karin Alvarez, René Assenberg, et al.
Nature Methods|June 20, 2017
High-speed fixed-target serial virus crystallographyPhilip Roedig, Helen M Ginn, Tim Pakendorf, et al.
Pageof 32